Market Research Logo

Global Muscle Relaxant Drugs Market 2017-2021

Global Muscle Relaxant Drugs Market 2017-2021

About Muscle Relaxant Drugs

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints.

Technavio’s analysts forecast the global muscle relaxant drugs market to grow at a CAGR of 5.64% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global muscle relaxant drugs market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Muscle Relaxant Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Pfizer
  • Ipsen Group
  • Allergan
  • Novartis
  • Teva Pharmaceuticals
Other prominent vendors
  • Acorda Therapeutics
  • Aldeyra Therapeutics
  • Canbex Therapeutics
  • Daewoong
  • Emcure Pharmaceuticals
  • Endo International
  • Fresenius Kabi
  • Galderma
  • INSYS Therapeutics
  • Johnson & Johnson
  • Lannett Company
  • Merz Pharma
  • Mylan
  • Par Pharmaceutical
  • PhytoTech Therapeutics
  • Revance Therapeutics
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceutical
Market driver
  • Presence of a large patient pool driving adoption rates.
  • For a full, detailed list, view our report
Market challenge
  • Side effects associated with use of muscle relaxants hamper adoption rates.
  • For a full, detailed list, view our report
Market trend
  • Advanced drug delivery technologies fuels adoption of muscle relaxants.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • An overview of muscle spasticity and spasms
    • Table Key muscle relaxants
  • Pipeline landscape
    • Table Pipeline landscape
  • Market landscape
    • Market overview
      • Table Global muscle relaxant drugs market snapshot
      • Table Global muscle relaxant drugs market 2016-2021 ($ millions)
      • Table Opportunity analysis in global muscle relaxant drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product category
    • Table Global muscle relaxant drugs market by product category 2016
    • Skeletal muscle relaxant drugs
      • Table Global skeletal muscle relaxant drugs market 2016-2021 ($ millions)
    • Facial muscle relaxant drugs
      • Table Global facial muscle relaxant drugs market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Global muscle relaxant drugs market by geography 2016 and 2021
    • Table Global muscle relaxant drugs market revenue by geography 2016-2021 ($ millions)
    • Muscle relaxant drugs market in Americas
      • Table Market scenario in Americas
      • Table Muscle relaxant drugs market in Americas 2016-2021 ($ millions)
    • Muscle relaxant drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Muscle relaxant drugs market in EMEA 2016-2021 ($ millions)
    • Muscle relaxant drugs market in APAC
      • Table Market scenario in APAC
      • Table Muscle relaxant drugs market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Key approvals for new indications
      • Table Key factors driving the market growth
    • Impact of drivers on key customer segments
      • Table Impact of drivers
    • Market challenges
    • Impact of challenges on key customer segments
      • Table Impact of challenges
  • Market trends
    • Anti-aging treatments driving adoption of facial relaxants
    • Advanced drug delivery technologies fuels adoption of muscle relaxants
    • Growing use of muscle relaxants in new indications and applications
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global muscle relaxant drugs market 2016
      • Table Competitive analysis of global muscle relaxant drugs market
      • Table Strategic success factors of companies in global muscle relaxant drugs market
  • Key vendor analysis
    • Pfizer
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Allergan
      • Table Allergan: Key highlights
      • Table Allergan: Strength assessment
      • Table Allergan: Strategy assessment
      • Table Allergan: Opportunity assessment
    • Ipsen Group
      • Table Ipsen Group: Key highlights
      • Table Ipsen Group: Strength assessment
      • Table Ipsen Group: Strategy assessment
      • Table Ipsen Group: Opportunity assessment
    • Teva Pharmaceuticals
      • Table Teva Pharmaceuticals: Strength assessment
      • Table Teva Pharmaceuticals: Strategy assessment
      • Table Teva Pharmaceuticals: Opportunity assessment
    • Novartis
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report